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Abstract
OBJECTIVE: To investigate the effects of a modified
Dahuang Zhechong Pill (MDZP) on the angiogene-
sis of rhesus choroid-retina endothelial (RF/6A)
cells and its preliminary mechanism.
METHODS: A 3-(4, 5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazol-
ium (MTS) method was used to assess the effect of
a MDZP on RF/6A cell proliferation induced by vas-
cular endothelial growth factor (VEGF). Transwell in-
serts were used to assess the effect of the MDZP on
RF/6A cell migration. Matrigel was used to assess
the effect of the MDZP on the tube formation of RF/
6A cells. Western blotting and quantitative re-
al-time reverse transcription polymerase chain reac-
tion (RT-PCR) were used to detect the protein and
mRNA expression, respectively, of VEGF and matrix
metalloproteinase-2 (MMP-2) in RF/6A cells treated
with the MDZP.
RESULTS: RF/6A cell proliferation induced by VEGF
was inhibited by 0.2 mg/mL MDZP. At 0, 12.5, 25
and 50 mg/mL MDZP, the number of cells that mi-
grated through Transwell membranes was 73.33 ±
4.51, 61.33±4.04, 28.67±6.66 and 17.67±4.16, re-
spectively, and the number of tubes formed in
Matrigel was 20.33±0.58, 13.33±1.53, 11.00±1.00
and 1.33±0.58, respectively. At 100 and 200 mg/mL
MDZP, the protein and mRNA expression of VEGF
and MMP-2 were inhibited in RF/6A cells. At 400
mg/mL MDZP, the expression of VEGF mRNA and
MMP-2 protein were inhibited in RF/6A cells.
CONCLUSIONS: MDZP inhibits the angiogenesis of
RF/6A cells via the suppression of proliferation, mi-
gration and tube formation of RF/6A cells. Inhibi-
tion of the protein and mRNA expression of VEGF
and MMP-2 in RF/6A cells may be an important
mechanism.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Choroidal neovascularization (CNV) can be found in
wet age-related macular degeneration (AMD) and oth-
er eye diseases. CNV often occurs in the macula, caus-
ing repeated bleeding, leakage and scar formation re-
sulting in serious damage to visual function. The mech-
anism of CNV formation is very complicated. Various
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cytokines and signal transduction pathways play a part
in the occurrence and development of CNV. Currently,
anti-vascular drugs that target endothelial growth factor
(VEGF), which are injected into the vitreous cavity[1],
and photodynamic therapy (PDT) [2] are the latest
drugs and treatment technology of CNV. However, the
occurrence and development of CNV cannot be com-
pletely blocked and may relapse and produce various
complications. Moreover, these methods and drugs are
generally expensive[3], and broad application for treat-
ing the majority of patients in our country is limited.
Therefore, investigating safe, effective, inexpensive and
easily applied methods and drugs for the treatment of
CNV is extremely urgent.
Based on dry blood vacuity taxation treated by the Da-
huang Zhechong Pill (DZP) in Golden Chamber (《金
匮要略》) and modern medical findings, it is believed
that the funduscopic manifestations of fundus macular
hemorrhage due to CNV are linked to the internal dry
blood and darkish eyes of dry blood vacuity taxation
described by Zhang Zhong-jing. Thus, the traditional
Chinese medicine (TCM) assumption that the
pathomechanism of CNV formation is the dry blood
within eyes as the tip and generalized vacuity taxation
as the root was proposed. The formula of a Modified
Dahuang Zhechong Pill (MDZP) was composed to
treat patients with CNV-related diseases including
AMD, which achieved a marked improvement in visu-
al function via promoting absorption of hemorrhages
and exudation, as well as alleviating edema and mem-
brane formation[4]. Therefore, in this study, we ob-
served the effects of MDZPs on proliferation, migra-
tion and tube formation, as well as VEGF and matrix
metalloproteinase 2 (MMP-2) expression in rhesus cho-
roid-retina endothelial (RF/6A) cell line in vitro. Our
aim was to clearly understand the role that MDZPs
play in manipulating the angiogenesis of RF/6A cells
and explore its preliminary mechanism to provide an
experimental basis for clinical application of MDZPs
to treat CNV-related diseases such as wet AMD.
MATERIALS ANDMETHODS
Materials
The rhesus choroid-retina endothelial cell line RF/6A
(Cell Bank of the Chinese Academy of Sciences) was
purchased from the Cell Resource Center of the Shang-
hai Institute of Health Science of the Chinese Acade-
my of Sciences (Shanghai, China).
The TCM compound formula for the MDZP was
modified from the classic formula for the Dahuang
Zhechong Pill. Chinese medicinal materials (63 g)
were soaked in double-distilled water for 60 min,
boiled for 30 min and then filtered. The residues were
combined with double-distilled water, boiled for 20
min and filtered again. The two parts of the filtrate
were mixed and filtrated again, followed by precipita-
tion with 95% ethanol. The ethanol was decompressed
and recovered. The water decoction was concentrated
to 1 g crude drug/mL. The supernatant was obtained
by centrifugation at 3000 rpm followed by filter steril-
ization through a microporous membrane (0.22 μm)
and then stored at–30°C. The supernatant was dilut-
ed to the desired concentration with RPMI 1640 medi-
um. Except for Meng Chong (Tabanus Bivittatus) and
Qi Cao (dried grub larva), which were provided by Mr.
Zhu Jin-er of Shanghai Caitong Detang Pharmaceuti-
cal Factory for Chinese Materia Medica (Shanghai,
China), raw medicinal materials were purchased from
the Pharmacy of the First People's Hospital Affiliated
with Shanghai Jiaotong University (Shanghai, China).
Recombinant human VEGF (V7259) and protamine
sulfate (P4020), Sigma-Aldrich Co., (St. Louis, MO,
USA), were dissolved in phosphate-buffered saline
(PBS) at 10 ng/μL and 1 mg/mL, respectively, and
stored at–30°C.
Novel tetrazole derivatives MTS (G3580), Promega
Corporation (Madison, WI, USA), was purchased
from Shanghai Sheng Zhao Biotechnology Co., Ltd.;
Transwell chambers (3422), Corning Incorporated
(Corning, NY, USA), were purchased from Shanghai Ji
Tai Biotechnology Co., Ltd., and Matrigel (354234),
BD (Franklin Lakes, NJ USA), was purchased from Ge-
netic Science and Technology Co., Ltd. (Shanghai, Chi-
na).
Rabbit anti-human VEGF165 affinity purified poly-
clonal antibody (AB1442), Millipore (CHEMICON),
and rabbit anti-MMP-2 (hinge region) polyclonal anti-
body (AB809), Millipore (CHEMICON), were pur-
chased from Shanghai Ming Rui Bio-Technology Co.,
Ltd.
A cell and tissue total protein extraction kit (KC-415),
Shanghai Kang Cheng Bioengineering Co., Ltd. Shang-
hai, China); BCA protein assay kit (AR0146), Wuhan
Boster Bioengineering Co., Ltd. (Wuhan, China);
low-temperature centrifuge, Shanghai An Ting Science
and Medical Instrument Factory (Shanghai, China);
Microplate Reader, Thermo Fisher Scientific Inc.
(Waltham, MA, USA); SYBR Green I RT-PCR Master
Mix, TOYOBO Co. Ltd. (Osaka, Japan); RT-kit, Fer-
mentas International Inc. (Burlington Ontario, Cana-
da); SuperScript II reverse transcriptase, Invitrogen
Corporation (Grand Island, NY, USA); DU600-UV
spectrophotometer, Beckman, Inc. (Brea, CA, USA);
quantitative real-time PCR instrument, ABI Prism
7300, Applied Biosystems, Inc. (Foster City, CA, USA).
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MTS Cell Proliferation Assay
RF/6A cells in a logarithmic growth phase were collect-
ed and adjusted to 8 × 104 cells/mL with RPMI 1640
supplemented with 10% calf serum and then incubat-
ed in 96 well culture plates (100 μL cell suspension per
well) at 37°C in a 5% CO2 incubator. After 24 h, cells
were washed twice PBS and then incubated for another
24 h in serum-free culture medium. Then, 100 μL vari-
ous conditional serum-free culture medium was added
to wells. After 20 μL MTS was added to each well,
cells were incubated in the dark at 37°C for 3 h. The
optic absorption (A value) of each well was then mea-
sured at 490 nm and the A490 value was analyzed to indi-
cate cell proliferation levels. Eight wells of cells were
used for each group. The experiment was repeated at
least three times.
Cell Migration Assay with Transwell Chambers
RPMI 1640 culture medium was added to a 12 well
plate and then to the transwell inserts. The plate was
then incubated at 37°C in a 5% CO2 incubator over-
night. Transwell inserts contained fresh RPMI 1640
medium supplemented with 10% calf serum (600 μL
medium per well), and serum-free culture medium and
cells in the inside compartment. RF/6A cell density
was adjusted to 4×106 cells/mL. Cell were incubated at
37°C with 5% CO2 for 24 h in 100 μL various condi-
tional serum-free culture medium. Then, transwell in-
serts were removed, the liquid inside was absorbed
with a dry cotton swab, and cells on the surface of the
polycarbonate membrane were gently wiped with a dis-
tilled water-soaked cotton swab. Cells were fixed with
4% paraformaldehyde for 20 min and then PBS
washed three times. The polycarbonate film was care-
fully cut from the base of the chamber and mounted
on a glass slide. After staining with hematoxylin for 1
min, samples were rinsed several times with tap water
and then transparentized with dimethylbenzene for 2–
3 min followed by mounting with neutral resin. Cells
attached to the lower surface of the polycarbonate
membrane were photographed in five randomly chosen
visual fields under a microscope. The number of cells
that migrated underneath the transwell membrane was
counted and averaged with IPP 6.0 image analysis soft-
ware. Three wells of cells were used for each group.
The experiment was repeated at least three times.
Tube Formation Assay of Endothelial Cells with
Matrigel
Matrigel was thawed at 4°C overnight. Equipment and
96 well plates were placed on ice prior to the proce-
dure. Liquid Matrigel (100 μL) was slowly added to
each well followed by carefully shaking for even distri-
bution. All the above processes were carried out on ice.
Then, the culture plate was incubated at 37° C with
5% CO2 for 0.5–1 h. RF/6A cells were collected and
adjusted to 1.6×106 cells/mL with RPMI 1640 supple-
mented with 20% calf serum and then incubated in
the 96 well culture plate (50 μL cell suspension and 50
μL conditional serum-free medium per well) at 37°C
with 5% CO2 for 24 h. Cells in five randomly chosen
visual fields were recorded under a phase contrast mi-
croscope after 3, 6, 12 and 24 h. The number of
full-formed tubes was counted and averaged[5]. Three
wells of cells were used for each group. The experiment
was repeated at least three times.
Western Blotting
RF/6A cells were collected and adjusted to 10[6,7] cells/
mL with RPMI 1640 supplemented with 10% calf se-
rum and incubated in culture dishes (4 mL cell suspen-
sion per dish) at 37 °C with 5% CO2 until attached.
Cells were then incubated with serum-free culture me-
dium for 4 h and then serum-free culture medium con-
taining 10 ng/mL VEGF and experimental drugs at
various concentrations for 24 h. Four dishes of cells
were used for each group. Cells were PBS washed
twice, and total protein extraction reagents containing
protease inhibitors were added to dishes followed by
gentle shaking for 5 min. Cells were transferred to a
centrifuge tube and shaken for 15 min in an ice bath,
then centrifuged at 12000×g for 15 min to collect the
supernatant. Protein concentration was measured ac-
cording to the manufac
Quantitative Real-time RT-PCR
RF/6A cells were collected and adjusted to 10[6-7] cells/
mL with RPMI 1640 supplemented with 10% calf se-
rum and then incubated in a 6 well culture plate (2 mL
cell suspension per well) at 37°C with 5% CO2 until at-
tached. Cells were then incubated with serum-free cul-
ture medium for 4 h and then serum-free culture medi-
um containing 10 ng/mL VEGF and the experimental
drug at various concentrations for 24 h. Four wells of
cells were used for each group. Total RNA was extract-
ed with Trizol reagent (Invitrogen). RNA concentra-
tion was determined by a UV spectrophotometer.
RNA quality was assessed by 1% formaldehyde dena-
turing gel electrophoresis. Reverse transcription was
carried out according to the manufacturer's instruc-
tions for Superscript II (Invitrogen Corporation), in
which cDNA was obtained and stored at – 20° C.
VEGF forward primer: 5' TTACCTGCGACTGAGA-
AA 3', reverse primer: 5' GAGTGGCAGTGAG-
GTTTT 3', product length 145 bp. MMP-2 forward
primer: 5' GTGGATGATGCCTTTGCT 3', reverse
primer: 5' TCCGTCCTTACCGTCAAA 3', product
length 150 bp. Housekeeping gene β-actin forward
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primer: 5' TATGACTTAGTTGCGTTACACC 3', re-
verse primer: 5' CCTTCACCGTTCCAGTTT 3',
product length 155 bp. Primers were synthesized by
Shanghai Sheng Gong Bio-Engineering Co., Ltd.
The total reaction volume of SYBR Green I real-time
PCR was 20 μL: 10 μL 2× QuantiTect SYBR Green I
RT-PCR Master Mix; 1 μL each forward (10 μmol/L)
and reverse (10 μmol/L) primers at a 0.15 mol/μL final
concentration; 0.2 μL QuantiTect RT Mix; 1 μL tem-
plate cDNA; 6.8 μL DNAase water. PCR reaction con-
ditions were: 50°C for 2 min (×1), 95°C for 10 min (×
1), 94°C for 15 s→ 59°C for 20 s→ 72°C for 30 s (×
45). After each cycle, the absorbance values and melt-
ing curves of products were measured. The target gene
expression level of each sample was relative to the β-ac-
tin gene and calculated based on 2-DCt. DCt=Ct (target
gene)–Ct (β-actin). The relative target gene expres-
sion level in the experimental drug group was relative
to that in the control group gene and expressed as
2-DDCt6, while 1 was set for the control group. Compared
with that in the control group, the relative gene expres-
sion level of the drug group was expressed as a multiple
N=2-DDCt, in which DDCt=DCt (drug group)–DCt (control
group).
Statistical Analysis
Measurement data were expressed as the mean ± stan-
dard deviation ( xˉ ±s). SPSS 14.0 software was used for
statistical analysis. One-way analysis of variance was
used for comparisons between groups. Treatment
groups were compared to a control group with Dun-
nett's tests. A P value less than 0.05 was considered sta-
tistically significant.
RESULTS
Effects of the MDZP on RF/6A Cell Proliferation
Induced by VEGF
MTS experiments showed that compared with that of
group 2, i.e. the VEGF-induced RF/6A cell prolifera-
tion group, the A values of group 3, i.e. the protamine
positive control group and group 5, i.e. MDZP at the
concentration of 0.2 g/mL were significantly reduced
with statistical significance (P<0.05), while that of
MDZP at lower (0.1 g/mL, group 4) and higher con-
centrations (0.4 g/mL, group 6) showed no significant
changes (P>0.05) (Table 1). This result indicated that
0.2 g/mL MDZP inhibited RF/6A proliferation in-
duced by VEGF.
Effects of the MDZP on RF/6A Cell Migration
Transwell chamber experiments showed that compared
with that of group 1, i.e. the negative control group,
the number of cells that migrated underneath the tran-
swell membrane of the MDZP group at 12.5 mg/mL
was reduced with statistical significance (P<0.05),
while that of the MDZP group at 25 and 50 mg/mL
was reduced with high statistical significance (P<0.01)
(Table 2, Figure 1). This result suggested that 12.5, 25
and 50 mg/mL MDZP inhibited RF/6A cell migration
in a dose-dependent manner.
Table 1 Effects of the MDZP on RF/6A Cell Proliferation In-
duced by VEGF
Group
1
2
3
4
5
6
Drug Concentration
—
VEGF
VEGF
Protamine
VEGF
MDZP
VEGF
MDZP
VEGF
MDZP
—
10ng/mL
10ng/mL
200μg/mL
10ng/mL
0.1g/mL
10ng/mL
0.2g/mL
10ng/mL
0.4g/mL
A value( xˉ ±SD)
1.82±0.10★
2.10±0.06
1.38±0.04★
2.03±0.13
1.39±0.01★
2.07±0.11
n
8
8
8
8
8
8
Notes: ★P<0.05 vs. group 2.
Table 2 Effects of the MDZP on RF/6A Cell Migration
Group
1
2
3
4
Drug Concentration
—
MDZP
MDZP
MDZP
—
12.5 mg/mL
25 mg/mL
50 mg/mL
Cells ( xˉ ±SD)
73.33±4.51
61.33±4.04★
28.67±6.66★★
17.67±4.16★★
n
3
3
3
3
Notes: ★P<0.05, ★★P<0.01 vs. group 1.
Effects of the MDZP on the Tube Formation of RF/
6A Cells
After 3 h of culture, tube formation of group 1, i.e. the
negative control group was observed in Matrigel experi-
ments. At 12 h, tube formation was most evident and
did not significantly change thereafter, therefore imag-
es at 12 h were used to observe tube formation. Com-
pared with that of group 1, the number of tubes
formed in Matrigel by the MDZP group at 12.5, 25,
and 50 mg/mL was reduced with high statistical signifi-
cance (P<0.01) (Table 3, Figure 2), indicating that
12.5, 25 and 50 mg/mL MDZP inhibited the tube for-
mation of RF/6A cells in a dose-dependent manner.
VEGF and MMP-2 Protein Expression
Western blotting showed that compared with that of
group 1, i.e. the negative control group, VEGF and
MMP-2 protein expression in group 3– 5, i.e. 100,
200, and 400 mg/mL MDZP, and group 2, i.e. the
200 μg/mL protamine sulfate group, were reduced
with high statistical significance (P<0.01), but that of
VEGF at 400 mg/mL did not significantly reduce (Fig-
ure 3). This result indicated that MDZP at the corre-
sponding concentrations inhibited MMP-2 protein ex-
pression in RF/6A cells.
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Figure 1 Effects of the MDZP on RF/6A Cell Migration (×200). (A: untreated; B: 12.5 mg/mL MDZP; C: 25 mg/mL MDZP; D: 50 mg/
mL MDZP).
Table 3 Effects of the MDZP on the Tube Formation of RF/6A Cells
Group
1
2
3
4
Drug Concentration
—
MDZP
MDZP
MDZP
—
12.5 mg/ml
25 mg/ml
50 mg/ml
Tubes ( xˉ ±SD)
20.33±0.58
13.33±1.53★★
11.00±1.00★★
1.33±0.58★★
n
3
3
3
3
Notes: ★★P<0.01 vs. group 1.
Figure 2 Effects of the MDZP on the Tube Formation of RF/6A Cells (phase-contrast microscopy, ×100) (A: untreated; B: 12.5 mg/mL
MDZP; C: 25 mg/mL MDZP; D: 50 mg/mL MDZP).
Figure 3 VEGF and MMP-2 Protein Expression. (Group 1 i.e.
the negative control group, group 2 i.e. the protamine control
group, group 3–5 i.e. 100, 200, and 400 mg/mL MDZP, re-
spectively. ★★P<0.01 vs. group 1).
VEGF and MMP-2 mRNA Expression
RNA Quality: UV spectrophotometer analysis indicat-
ed that the A260/A280 ratios were 1.8– 2.0, suggesting
that RNA purity was adequate. RNA concentrations
were 0.2–1.2 g/mL. Ribosomal 18s and 28s subunit
bands in 1% formaldehyde denaturing gel electropho-
resis were clearly visible, indicating high RNA integri-
ty, with no obvious degradation (Figure 4).
Figure 4 RNA Denaturing Polyacrylamide Gel Electro-
phoresis.
Specificity of PCR Products: Specific peaks of melting
curves indicated few non-specific PCR products and
few primer dimmers. The results of non-specific peaks
were removed (Figure 5).
RT-PCR Results: Quantitative real-time RT-PCR
showed that compared with that of group 1, i.e. the
negative control group, VEGF and MMP-2 mRNA ex-
pression in group 3–5 i.e. 100, 200 and 400 mg/mL
MDZP, and group 2, i.e. the 200 μg/mL protamine
sulfate group, were significantly reduced (P<0.05), but
that of MMP-2 at 400 mg/mL MDZP was not signifi-
cantly reduced (Figure 6). This result indicated that
MDZP at the corresponding concentrations inhibited
VEGF and MMP-2 mRNA expression in RF/6A cells.
A DB C
A DB C
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Figure 5 Amplification A and melting B curves (three peaks represent MMP-2, VEGF and β-actin, respectively) of quantitative re-
al-time PCR.
Figure 6 VEGF and MMP-2 mRNA Expression. (Group 1 i.e.
the negative control group, group 2 i.e. the protamine con-
trol group, group 3–5 i.e. 100, 200 and 400 mg/mL MDZP,
respectively. ★P<0.05 vs. group 1)
DISCUSSION
Angiogenesis is a series of complicated biological pro-
cesses, which involves vascular dilation, increased vascu-
lar permeability and degradation of the surrounding
matrix, followed by activation, migration, prolifera-
tion, budding growth and tube formation of endotheli-
al cells, with remodeling of neovascularization resulting
in vascular nets[7,8]. CNV formation is a process of com-
plex morphological changes involving various ele-
ments, which are strictly regulated. It consists of base-
ment membrane degradation, endothelial cell migra-
tion and proliferation, and capillary formation. De-
spite the fact that its formation mechanism has not
been fully clarified, injury or composition changes of
the Bruch membrane, MMP activation and expression
changes of vascular growth and inhibitory factors are
important steps in the early stage of CNV.
Various cytokines are involved in the regulation of
CNV formation, among which VEGF is presently be-
lieved to be the most important. VEGF is believed to
be the most powerful factor to promote angiogenesis
and is an endothelial cell mitogen, which selectively
stimulates proliferation and migration[9] as well as in-
duces anti-apoptotic protein expression in endothelial
cells[10], and increases vascular permeability, thereby in-
ducing angiogenesis in vivo. Thus, VEGF is a funda-
mental factor in regulating angiogenesis and plays a
unique role in the regulation of vascular physiology
and pathological growth. A slow VEGF increase stimu-
lates the proliferation of choroidal endothelial cells that
breakthrough the Bruch membrane and the barrier of
the retinal pigment epithelium (RPE), and eventually
develops into CNV[11]. VEGF over-expression has been
identified as an important factor in the pathological
process of CNV-related diseases such as AMD, thus,
treatments targeting VEGF such as Lucentis, Avastin,
VEGF-trap and small interfering RNA have become a
research focus of the prevention and treatment of CNV.
Degradation of the basement membrane and extracellu-
lar components caused by an imbalance of the MMP /
tissue inhibitor of metalloproteinase (TIMP) system is
believed to be the key in CNV formation. MMPs are
the most important proteinases involved in degrada-
tion of basement membranes and the extracellular ma-
trix, which can degrade almost all components of the
extracellular matrix and play a key role in promoting
angiogenesis. The current study of the relationship be-
tween MMPs and CNV is focused on the gelatinases of
the MMPs, namely MMP-2 and MMP-9, which main-
ly degrade type IV collagen to allow the migration of
vascular endothelial cells. In particular, MMP-2 plays
an important role in the pathogenesis of CNV. RPE
cells are an important source of MMPs in the microen-
vironment of the outer retina. Cultured human RPE
cells secrete MMP-2 in a stationary state. Stimulation
with tumor necrosis factor-α, VEGF and fibronectin
cause RPE cells to increase MMP-2 secretion and pro-
mote CNV formation[12]. MMP expression exists in the
CNV membranes of patients with AMD. In the subfo-
veal vascular membrane of the macula lutea in AMD,
MMP-2 is mainly expressed in endothelial cells and dis-
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tributed at the formation of new blood vessels[13].
In this study, various MDZP concentrations affected
the angiogenesis of RF/6A cells in vitro. MDZP at 0.2
g/mL inhibited RF/6A cell proliferation induced by
VEGF. MDZP at 12.5, 25 and 50 mg/mL inhibited
the migration and tube formation of RF/6A cells in a
dose-dependent manner. At 100 and 200 mg/mL
MDZP, protein and mRNA expression of VEGF and
MMP-2 was inhibited in RF/6A cells. At 400 mg/mL
MDZP, the expression of VEGF mRNA and MMP-2
protein was inhibited in RF/6A cells.
In conclusion, MDZP inhibits the angiogenesis of RF/
6A cells via suppression of proliferation, migration and
tube formation of RF/6A cells. The mechanism is like-
ly to be related to the inhibition of mRNA and protein
expression of VEGF and MMP-2 in RF/6A cells. DZP
has an anti-tumor effect in clinical observation[14] and
experimental research[15], and inhibits angiogenesis in
the chick embryo chorioallantoic membrane (CAM)[16].
In our preliminary experiments, MDZP inhibited an-
giogenesis in the chick CAM. CNV tissue is similar to
tumor tissue, in which both are rich in neovasculariza-
tion. This study provides a preliminary in vitro experi-
mental basis for application of MDZP in the clinical
treatment of CNV-related diseases. However, because
of its complexity, the relationship between MDZP con-
centration and its inhibiting effects on proliferation as
well as VEGF and MMP-2 expression in RF/6A cells,
further study is required. In addition, because of the di-
versity of MDZP ingredients with varied actions in
multiple pathways and targets, its detailed mechanism
may not be confined to the inhibition of VEGF and
MMP-2 expression, and the mechanism of other as-
pects still remain to be researched.
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